World’s thinnest pen needle!
 

NANOPASS 34 is 22% thinner than 32G.

• Pain is primarily related to needle thickness. There are 100-200 pain receptors per cm² human skin surface. NANOPASS 34 decreases the probability of touching the pain receptors and therefore makes the insulin injection virtually painless.
• NANOPASS 34 causes less skin trauma than larger needle sizes, which results in less pain.
• The unique asymmetric edge of NANOPASS cuts the skin instead of puncturing it.
• This decreases the resistance while penetrating the skin. Another step towards virtually painless insulin injection.
• The patented slim double tapered needle shape reduces the insulin injection force significantly.
• Although the needle tip is 34G, NANOPASS 34 provides less injection force than a conventional 32G pen needle.
• NANOPASS 34 combines virtually painless injection with easy handling.

• Needle tip diameter: 34G (0.18mm)
• Needle length: 4mm